false
OasisLMS
Catalog
CHEST Guidelines
Methodology-for-Development-of-Guidelines-for-Lung
Methodology-for-Development-of-Guidelines-for-Lung
Back to course
Pdf Summary
The third edition of the "Diagnosis and Management of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines" presents enhancements in clinical decision-making guidance, aiming to improve patient outcomes. Developed by the American College of Chest Physicians (ACCP), these guidelines inform multidisciplinary audiences, including healthcare professionals and researchers, about the latest best practices in lung cancer diagnosis and management.<br /><br />The guidelines were crafted by a specialized panel of experts free from conflicts of interest. The development process employed a Population, Intervention, Comparator, Outcome (PICO) framework to formulate questions and guide evidence searches. Quality assessments of studies ranged from randomized controlled trials to observational studies. Evidence-based recommendations were drafted after a rigorous review, necessitating consensus among the panelists, with voting processes implemented for controversial recommendations.<br /><br />The guidelines address advancements in lung cancer staging by integrating invasive and noninvasive methods, and introduce new focuses, such as bronchial intraepithelial neoplasia and the complexities of early central airway tumors. A comprehensive approach to tobacco use treatment in lung cancer patients underscores the guidelines' scope expansion.<br /><br />Recommendations are graded based on the strength and quality of available evidence. Strong recommendations, using phrases like "we recommend," suggest firm evidence or benefit-risk clarity, while weaker suggestions arise from more balanced considerations of benefits and risks.<br /><br />Principally disseminated through the CHEST journal, the guidelines also aim to inform practice by considering patient values and resource availability, facilitating individual physician-patient decision-making. Looking ahead, ACCP plans to implement a living guidelines model, allowing more dynamic updates aligned with emerging research, offering clinicians fast, accessible, and up-to-date evidence at the point of care through CHEST Evidence. The guidelines are supported by a robust internal and external review process, ensuring reliability and broad acceptance across relevant professional societies.
Keywords
lung cancer
ACCP guidelines
clinical decision-making
multidisciplinary
PICO framework
evidence-based recommendations
lung cancer staging
bronchial intraepithelial neoplasia
tobacco use treatment
living guidelines model
×
Please select your language
1
English